Concepedia

Author

A. Stern

Fondazione IRCCS Istituto Nazionale dei Tumori

Also Known As

A C Stern, A Stern, A. C. Stern, A. Stern, A., Stern, AngelikaC. Stern, Asaf Stern, Aysche Stern, G. Solbu

25

Publications

1.3K

Citations

8

H-Index

23

Concepts

All Affiliations

Fondazione IRCCS Istituto Nazionale dei Tumori
AS

About

A. Stern is an author at Fondazione IRCCS Istituto Nazionale dei Tumori specializing in medicine, cell transplantation, and cancer research.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

960

2

Immunology

2

2

948

3

Blood Transplantation

1

1

750

4

Cell Biology

1

1

750

5

Marrow Transplantation

1

1

750

A. Stern

×

6

Publications

1.2K

Citations

6

H-Index

YearCitations

GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR TO HARVEST CIRCULATING HAEMOPOIETIC STEM CELLS FOR AUTOTRANSPLANTATION

AlessandroM. Gianni, Marco Bregni, A. Stern,

The Lancet

1989

750

Recombinant human granulocyte-macrophage colony-stimulating factor reduces hematologic toxicity and widens clinical applicability of high-dose cyclophosphamide treatment in breast cancer and non-Hodgkin's lymphoma.

Alessandro M. Gianni, Marco Bregni, Salvatore Siena,

Journal of Clinical Oncology

1990

198

Tetrabenazine Treatment in Movement Disorders

Diana Paleacu, Nir Giladi, O Moore,

Clinical Neuropharmacology

2004

97

High-dose sequential chemoradiotherapy, a widely applicable regimen, confers survival benefit to patients with high-risk multiple myeloma.

Alessandro M. Gianni, Corrado Tarella, Marco Bregni,

Journal of Clinical Oncology

1994

78

Characterization of accessory cells required for helper T cell induction <i>in vitro</i>: evidence for a phagocytic, Fc-receptor, and Ia-bearing cell type.

Peter Erb, A. Stern, Ş. Ş. Alkan,

The Journal of Immunology

1980

22

Abstract A212: First in human phase I study of PRS-050 (Angiocal), a VEGF-A targeting anticalin, in patients with advanced solid tumors: Results of a dose escalation study.

K. Mross, R. Fischer, Heike Richly,

Molecular Cancer Therapeutics

2011

12

Page 1